AGMB
AgomAb Therapeutics NV
NASDAQ · Healthcare · Biotechnology · BE
$6.85
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-47.8%
Return on equity
-40.7%
Return on assets
-44.9%
Return on invested capital
0.00x
Asset turnover
-$57.9M
Cash from operations
$2.65
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025